Works matching IS 14752840 AND DT 2016 AND VI 15

Results: 163
    1
    2
    3

    Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0480-8
    By:
    • Rizzo, Manfredi;
    • Rizvi, Ali A.;
    • Patti, Angelo Maria;
    • Nikolic, Dragana;
    • Giglio, Rosaria Vincenza;
    • Castellino, Giuseppa;
    • Volti, Giovanni Li;
    • Caprio, Massimiliano;
    • Montalto, Giuseppe;
    • Provenzano, Vincenzo;
    • Genovese, Stefano;
    • Ceriello, Antonio
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Impact of diabetes on the predictive value of heart failure biomarkers.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0470-x
    By:
    • Alonso, Nuria;
    • Lupón, Josep;
    • Barallat, Jaume;
    • de Antonio, Marta;
    • Domingo, Mar;
    • Zamora, Elisabet;
    • Moliner, Pedro;
    • Galán, Amparo;
    • Santesmases, Javier;
    • Pastor, Cruz;
    • Mauricio, Dídac;
    • Bayes-Genis, Antoni
    Publication type:
    Article
    15
    16
    17
    18

    Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0463-9
    By:
    • Sasso, Ferdinando Carlo;
    • Lascar, Nadia;
    • Ascione, Antonella;
    • Carbonara, Ornella;
    • De Nicola, Luca;
    • Minutolo, Roberto;
    • Salvatore, Teresa;
    • Rizzo, Maria Rosaria;
    • Cirillo, Plinio;
    • Paolisso, Giuseppe;
    • Marfella, Raffaele
    Publication type:
    Article
    19
    20

    Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0459-5
    By:
    • Shuhei Takahashi;
    • Kazunori Shimada;
    • Katsumi Miyauchi;
    • Tetsuro Miyazaki;
    • Eiryu Sai;
    • Manabu Ogita;
    • Shuta Tsuboi;
    • Hiroshi Tamura;
    • Shinya Okazaki;
    • Tomoyuki Shiozawa;
    • Shohei Ouchi;
    • Tatsuro Aikawa;
    • Tomoyasu Kadoguchi;
    • Shahi, Hamad Al;
    • Takuma Yoshihara;
    • Makoto Hiki;
    • Kikuo Isoda;
    • Hiroyuki Daida
    Publication type:
    Article
    21

    Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of nonculprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0464-8
    By:
    • Kennedy, Mark W.;
    • Fabris, Enrico;
    • Ijsselmuiden, Alexander J.;
    • Nef, Holger;
    • Reith, Sebastian;
    • Escaned, Javier;
    • Alfonso, Fernando;
    • van Royen, Niels;
    • Wojakowski, Wojtek;
    • Witkowski, Adam;
    • Indolfi, Ciro;
    • Ottervanger, Jan Paul;
    • Suryapranata, Harry;
    • Kedhi, Elvin
    Publication type:
    Article
    22
    23
    24
    25

    A 19-SNP coronary heart disease gene score profile in subjects with type 2 diabetes: the coronary heart disease risk in type 2 diabetes (CoRDia study) study baseline characteristics.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0457-7
    By:
    • Beaney, Katherine E.;
    • Ward, Claire E.;
    • Bappa, Dauda A. S.;
    • McGale, Nadine;
    • Davies, Anna K.;
    • Hirani, Shashivadan P.;
    • KaWah Li;
    • Howard, Philip;
    • Vance, Dwaine R.;
    • Crockard, Martin A.;
    • Lamont, John V.;
    • Newman, Stanton;
    • Humphries, Steve E.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33

    Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0449-7
    By:
    • Tanaka, Atsushi;
    • Murohara, Toyoaki;
    • Taguchi, Isao;
    • Eguchi, Kazuo;
    • Suzuki, Makoto;
    • Kitakaze, Masafumi;
    • Sato, Yasunori;
    • Ishizu, Tomoko;
    • Higashi, Yukihito;
    • Yamada, Hirotsugu;
    • Nanasato, Mamoru;
    • Shimabukuro, Michio;
    • Teragawa, Hiroki;
    • Ueda, Shinichiro;
    • Kodera, Satoshi;
    • Matsuhisa, Munehide;
    • Kadokami, Toshiaki;
    • Kario, Kazuomi;
    • Nishio, Yoshihiko;
    • Inoue, Teruo
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0429-y
    By:
    • Yukinori Harada;
    • Colleran, Roisin;
    • Kufner, Sebastian;
    • Giacoppo, Daniele;
    • Rheude, Tobias;
    • Michel, Jonathan;
    • Cassese, Salvatore;
    • Ibrahim, Tareq;
    • Laugwitz, Karl-Ludwig;
    • Kastrati, Adnan;
    • Byrne, Robert A.
    Publication type:
    Article
    42
    43
    44

    Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0437-y
    By:
    • Takahiro Sawada;
    • Hideo Tsubata;
    • Naoko Hashimoto;
    • Michinori Takabe;
    • Taishi Miyata;
    • Kosuke Aoki;
    • Soichiro Yamashita;
    • Shogo Oishi;
    • Tsuyoshi Osue;
    • Kiminobu Yokoi;
    • Yasue Tsukishiro;
    • Tetsuari Onishi;
    • Akira Shimane;
    • Yasuyo Taniguchi;
    • Yoshinori Yasaka;
    • Takeshi Ohara;
    • Hiroya Kawai;
    • Mitsuhiro Yokoyama
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids.

    Published in:
    Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0435-0
    By:
    • Beaney, Katherine E.;
    • Cooper, Jackie A.;
    • McLachlan, Stela;
    • Wannamethee, S. Goya;
    • Jefferis, Barbara J.;
    • Whincup, Peter;
    • Ben-Shlomo, Yoav;
    • Price, Jacqueline F.;
    • Kumari, Meena;
    • Wong, Andrew;
    • Ken Ong;
    • Hardy, Rebecca;
    • Kuh, Diana;
    • Kivimaki, Mika;
    • Kangas, Antti J.;
    • Soininen, Pasi;
    • Ala-Korpela, Mika;
    • Drenos, Fotios;
    • Humphries, Steve E.
    Publication type:
    Article